/MPAIX

MPAIX Stock - Morgan Stanley Insti Fd Advantage Portfolio Cl I

Q: What is the analyst price target for MPAIX?

Analyst price target information is not currently available for MPAIX.

Q: What is MPAIX's market cap?

Market capitalization information is not currently available for MPAIX.

Unknown|N/A|NASDAQ

$29.30+1.10%

+$0.32 (+1.10%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $32.23

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MPAIX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.84

52W High$31.24

52W Low$19.78

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$61.50B	$53.61B	$53.39B	$59.75B	$48.00B
Gross Profit	$61.50B	$53.61B	$53.39B	$59.75B	$48.00B
Gross Margin	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income	$29.55B	$23.55B	$24.76B	$29.82B	$23.09B
Net Income	$13.39B	$9.09B	$10.54B	$14.57B	$10.50B
Net Margin	21.8%	16.9%	19.7%	24.4%	21.9%
EPS	$7.60	$4.86	$6.15	$8.03	$6.46

Company Overview

The fund invests primarily in established companies with capitalizations within the range of companies included in the Russell 1000® Growth Index. In selecting securities for investment, the Adviser seeks to invest in companies with strong name recognition and sustainable competitive advantages. The fund may invest in foreign securities, which may include emerging market securities. It may invest in equity securities. The fund may also invest in privately placed and restricted securities.

Earnings History & Surprises

MPAIX

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$1.38

Q3 2023

EPS Surprise History

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$1.38	—	—

Frequently Asked Questions about MPAIX

What is MPAIX's current stock price?

Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX) is currently trading at $29.30 per share. The stock has moved +1.10% today.

What is the analyst price target for MPAIX?

No analyst price targets are currently available for this stock.

What sector is Morgan Stanley Insti Fd Advantage Portfolio Cl I in?

Morgan Stanley Insti Fd Advantage Portfolio Cl I operates in the N/A sector, specifically within the N/A industry. The company is traded on the NASDAQ exchange.

What is MPAIX's market cap?

Morgan Stanley Insti Fd Advantage Portfolio Cl I has a market capitalization of $0.22 billion, making it a small-cap company.

Does MPAIX pay dividends?

No, Morgan Stanley Insti Fd Advantage Portfolio Cl I does not currently pay a dividend to shareholders.